CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 37 filers reported holding CATALYST BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $51,000 | -63.0% | 102,095 | -22.9% | 0.00% | -60.0% |
Q2 2022 | $138,000 | +58.6% | 132,396 | 0.0% | 0.01% | +66.7% |
Q1 2022 | $87,000 | -28.1% | 132,396 | 0.0% | 0.01% | -14.3% |
Q4 2021 | $121,000 | -77.8% | 132,396 | 0.0% | 0.01% | -76.7% |
Q3 2021 | $544,000 | -20.6% | 132,396 | -16.3% | 0.03% | -21.1% |
Q2 2021 | $685,000 | – | 158,191 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |